SAB Biotherapeutics to present SAB-142 data at EASD meeting
SAB Biotherapeutics announced it will present data for SAB-142 at the upcoming 62nd Annual Meeting of the European Association for the Study of Diabetes.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
SAB Biotherapeutics announced it will present data for SAB-142 at the upcoming 62nd Annual Meeting of the European Association for the Study of Diabetes.